Import Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale from United States

Import trade data for Indian businesses

🇺🇸 United States — Country Profile

Capital

Washington D.C.

GDP (USD)

$25K

Population

331.0M

Currency

US Dollar

Trade Agreement

No preferential agreement

Import Snapshot

India imported $344K of medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale from United States in 2024 — +62.8% YoY.

Based on HS Code 3003 import data (UN Comtrade)

Import History — United States to India

2024

$344K

HS 3003 imports

2023

$211K

HS 3003 imports

2022

$1.5M

HS 3003 imports

About Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale Imports from United States

United States is one of the supplying countries for medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale to the Indian market, classified under HS heading 3003. Indian importers source this product for domestic consumption, manufacturing inputs, or re-export.

Export Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale to United States →Full export guide for United States →All imports from United States →